The main way that oestrogens potentiate the response of breast cancer cells to IGFs is probably by induction of the expression of components of the IGF signal transduction pathway [238] including type I IGF receptor [78, 239], IRS-1 [240–242], and IRS-2 [243]. Here, IGF1 is linked to breast carcinoma.